Page last updated: 2024-11-05

tetraethylammonium and Atrial Fibrillation

tetraethylammonium has been researched along with Atrial Fibrillation in 1 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dun, W1
Chandra, P1
Danilo, P1
Rosen, MR1
Boyden, PA1

Other Studies

1 other study available for tetraethylammonium and Atrial Fibrillation

ArticleYear
Chronic atrial fibrillation does not further decrease outward currents. It increases them.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:4

    Topics: Animals; Atrial Fibrillation; Chronic Disease; Dogs; Electric Conductivity; Heart; Potassium Channel

2003